The global pharmaceutical landscape is currently undergoing a massive overhaul with the advent of new technologies and cheaper and more efficient manufacturing techniques. This is paving the way for a whole new world of user-conscious drugs of the future. With big data, artificial intelligence, and a deeper understanding of the human body, the medical industry is on the verge of creating a deeper symbiotic relationship with modern tech unlike ever before.
Particularly, With respect to pharmaceutical manufacturing, real-time responsive drugs are still evolving out of the nascent stage. Yet, manufacturers have already begun exploring their predictive quality techniques. International Society for Pharmaceutical Engineering (ISPE) and its members are developing the roadmap to implement Pharma 4.0 model in the near future. Through complete digitalisation, Pharma 4.0 will connect the medical universe much more cohesively, creating new levels of transparency and speed for a digitalised plant floor. This will enable faster decision-making, and provide in-line and in-time control over business, operations, and quality. Manufacturing floor downtime and product waste will soon be minimised utilising robotic technology and artificial intelligence (AI). Also, single-use disposable solutions are gaining momentum replacing open transfer manufacturing techniques for safer drug storage and transport.
At this juncture, the key considerations must be made about how these most coveted technological solutions can be thoughtfully integrated into a business’ existing workflows. Organisations should consider a use-case driven approach to assessing their exact expectations from their technology partners. To assist businesses in such practice, we have compiled this issue of Pharma Tech Outlook. In this edition, we have listed the top 10 pharma tech companies in europe to highlight those making significant contributions to the advancement of the current and future trends alike. Equipped with innovative technological capabilities, these companies are set to transform the landscape. This edition also blends thought leadership articles from subject matter experts, CIOs, and CXOs, along with real-life stories on how the companies have enhanced their clients’ capabilities. We hope this issue of Pharma Tech Outlook helps you build the technological partnership your business needs to succeed in a competitive landscape.
We present to you Pharma Tech Outlook, “Top 10 Pharma Tech Companies in Europe-2020.”
